 |
|
|
|||
|
Renée E. Moore, Ph.D. She obtained her doctorate in neuroscience in 1996, and entered the clinical research arena in 1998. Renée has in-depth experience in global CRO settings managing programs to successful completion, and launched Progenitor in 2005. She is the accountable executive in Progenitor for operational, strategic and financial growth of the company, and is located in the Progenitor office in Germany. |
|
|
|
Klaus-Dieter Albrecht, RPh He obtained his registration as German Pharmacist in 1990, and entered the clinical research arena in the same year. Mr. Albrecht has 19 years of in-depth experience in clinical research. He worked as Director of Clinical Operations in local and international CROs. In his last position he lead the clinical contract and outsourcing department of a midsize pharmaceutical company and was responsible for annual contracting of 100 million Euros. As a founder of Progenitor he fills the position of the General Manager of the German business unit as well as the Senior Executive of business operations for Progenitor on a global scale. |
|
|
 |
Ambar Vaidya With over 15 years experience in the pharmaceutical industry and more than 12 years experience in clinical research, he was instrumental in the first incorporation of a global CRO to India and is now responsible for all aspects of Progenitor’s Indian operations. He has sound experience in a vast range of therapeutic areas including Oncology, CNS, Infectious Disease, Haematology, Immunology Dermatology, Nephrology, and Pain Management. |
|
|
 |
Anne Castillon She has over 20 years experience in the pharmaceutical development industry with 5 years in the CRO setting. Her core experience within global pharmaceutical companies was as the Head of the Oncology Unit within a Clinical Research Department. She has international experience as a Clinical Operation Manager based in Paris, responsible for Asian Operations. She has worked on more than 50 clinical research projects and has extensive experience leading trials across Latin America in multiple indications. She is responsible for strategically organizing and running the operational team in Latin America. |
||
|
Ian Rentsch He has the overall responsibility of leading Progenitor's Business Unit in Latin America, reporting to the CEO and Board of Directors at the European Headquarters. He has a legal background, graduated from the University of Buenos Aires in 1999 as a Lawyer specialized in Corporate Law, with over 10 years of Legal Corporate experience in German international Companies including Large Pharma and Trading companies. |
||
|
Kish Khan BA (Hons) She has over 5 years pharmaceutical experience and 9 years clinical research experience. Her breadth of experience includes sales and marketing management roles in both the pharmaceutical industry and large size CRO. At Progenitor she is responsible for all commercial aspects of the organisation, including the global leadership of the Proposals and Business Development teams. |
||
Copyright © Progenitor International Research |